Séverine Vermeire graduated as MD at the Catholic University of Leuven, Belgium. Part of her training was done at the Universidad Nacional de Asuncion, Paraguay (1993), and at the Montreal General Hospital (McGill University), Montreal, Canada (2000–2001). In 2001, she obtained her PhD on Genetic Polymorphisms and Serologic Markers in Inflammatory Bowel Disease as a Fellow of the National Funds for Scientific Research of Belgium (FWO). Part of her PhD was done at the University of Oxford, UK, at the Wellcome Trust Centre for Human Genetics with Professor Derek Jewell. Since 2003 she has been a full staff member at the Gastroenterology Department of the University Hospital Leuven and is appointed Professor of Medicine at the Catholic University of Leuven, Belgium.
Her scientific work has focussed on genetics and pharmacogenetics of IBD, on the role of the microbiome in IBD and on aspects related to immunogenicity of biological therapies. These research lines have resulted so far to more than 300 peer-reviewed full papers. She served as Associate Editor for GUT from 2004-2010 and is currently Associate Editor for the Journal of Crohn’s and Colitis. Dr Vermeire is Past-President of the Belgian IBD Research and Development Group (BIRD) and is currently President of the European Crohn’s and Colitis Organisation (ECCO). Her h-index is 76.